Study to Evaluate Efficacy of Aflibercept in Neovascular Age-related Macular Degeneration Patients Non Responders to Anti-Vascular Endothelial Growth Factor
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Carlos Juan Donate, MD
Hospital San Carlos, Madrid
Principal Investigator - Francisco Cabrera, MD
Hospital Universitario Insular de Canarias
Principal Investigator - Ignasi Jürgens, MD PhD
Institut Catala de Retina
Principal Investigator - Javier Araiz, MD
Instituto Clínico Quirúrgico de Oftalmología de Bilbao
Principal Investigator - Jordi Mones, MD PhD
Barcelona Macula Foundation
Principal Investigator - Jose Luis Olea, MD
Hospital Son Espases
Principal Investigator - Jose Maria Ruiz-Moreno, MD
Hospital Universitario de Albacete
Principal Investigator - Laura Sarasols, MD
Hospital Universitari General de Catalunya
Principal Investigator - Marta Suárez de Figueroa, MD
Hosipital Universitario Ramon y Cajal
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Barcelona Macula Foundation
Barcelona, Spain
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2013
- Primary completion
- 30 Nov 2014
- Completion
- 30 Jun 2015
- Last update posted
- 23 Nov 2018
- Registered enrollment
- 46
- Registry id
- NCT01896284
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.